Table 2

Odds of PRISm and variable obstruction based on eGFR and urinary albumin-creatinine ratio (UACR) in the entire cohort

PRISm*Variable obstruction†
Model 1Model 2Model 1Model 2
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
eGFR‡1.00 (1.00,1.01)0.301.00 (1.00,1.01)0.281.00 (0.99,1.00)0.310.99 (0.98,1.00)0.11
UACR‡1.24 (1.14,1.36)<0.00011.10 (1.01,1.21)0.030.97 (0.84,1.12)0.700.95 (0.81,1.12)0.55
UACR<30reference
UACR 30–3001.80 (1.42,2.29)<0.00011.33 (1.01,1.76)0.051.21 (0.79,1.85)0.361.23 (0.79,1.91)0.35
UACR>3003.01 (1.68,5.41)<0.0011.86 (1.01,3.42)0.051.83 (0.47,7.16)0.371.94 (0.47,8.03)0.35
eGFR>60reference
eGFR<601.23 (0.85,1.79)0.261.11 (0.78,1.58)0.561.62 (1.03,2.56)0.041.72 (1.07,2.74)0.03
  • Model 1: adjusted by age, sex, ethnicity, education, annual household income; Model 2: adjusted by model 1+BMI, hypertension, smoking, cardiovascular disease.

  • Bold values denote statistical significance (p < 0.05)

  • *PRISm was defined as FEV1<80% predicted and FEV1/FVC≥0.7.

  • †Variable obstruction was defined as prebronchodialator FEV1/FVC<0.7 and postbronchodialator FEV1/FVC≥0.7.

  • ‡As continuous variable.

  • BMI, body mass index; eGFR, estimated glomerular filtration rate; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PRISm, preserved ratio impaired spirometry.